Zobrazeno 1 - 10
of 391
pro vyhledávání: '"Robert P, Hasserjian"'
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-16 (2024)
Abstract In 2022, two new classifications of myeloid neoplasms and acute leukemias were published: the 5th edition WHO Classification (WHO-HAEM5) and the International Consensus Classification (ICC). As with prior classifications, the WHO-HAEM5 and I
Externí odkaz:
https://doaj.org/article/70e4f343cc424afda6f367c600d6edb6
Autor:
Joshua R. Menke, Umut Aypar, Charles D. Bangs, Stephen L. Cook, Srishti Gupta, Robert P. Hasserjian, Christina S. Kong, Oscar Lin, Steven R. Long, Amy Ly, Jacob A. S. Menke, Yasodha Natkunam, Roberto Ruiz-Cordero, Elizabeth Spiteri, Julia Ye, Sara L. Zadeh, Dita A. Gratzinger
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionFluorescence in situ hybridization (FISH) is an essential ancillary study used to identify clinically aggressive subsets of large B-cell lymphomas that have MYC, BCL2, or BCL6 rearrangements. Small-volume biopsies such as fine needle aspi
Externí odkaz:
https://doaj.org/article/cd9351f85bad47e783ac6d5daa3673ca
Autor:
Olga K. Weinberg, Miguel D. Cantu, Jeffrey Gagan, Yazan F. Madanat, Daniel A. Arber, Robert P. Hasserjian
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 760-764 (2023)
Abstract A group of gene mutations has been identified to be strongly associated with secondary acute myeloid leukemias (AML) arising from prior myeloid neoplasms. The International Consensus Classification (ICC) and proposed 5th edition of the World
Externí odkaz:
https://doaj.org/article/04fbfac216474c0c84b3e58d4c915b53
Autor:
C. Cameron Yin, Wayne Tam, Serena M. Walker, Amandeep Kaur, Madhu M. Ouseph, Wei Xie, Olga K.Weinberg, Peng Li, Zhuang Zuo, Mark J. Routbort, Simon Chen, L. Jeffrey Medeiros, Tracy I George, Attilio Orazi, Daniel A. Arber, Adam Bagg, Robert P. Hasserjian, Sa A. Wang
Publikováno v:
Haematologica, Vol 109, Iss 6 (2023)
STAT5B has been reported as a recurrent mutation in myeloid neoplasms with eosinophilia, but its overall frequency and importance across a spectrum of myeloid neoplasms are largely unknown. We conducted a multicenter study on a series of 82 myeloid n
Externí odkaz:
https://doaj.org/article/d278b8f93dc24bc5a9ea8b492101f78d
Autor:
Zhengping Huang, Xiaomeng You, Liang Chen, Yan Du, Kailey Brodeur, Hyuk Jee, Qiang Wang, Grace Linder, Roxane Darbousset, Pierre Cunin, Margaret H. Chang, Alexandra Wactor, Brian M. Wauford, Marc J. C. Todd, Kevin Wei, Ying Li, Anais Levescot, Yoichiro Iwakura, Virginia Pascual, Nicole E. Baldwin, Pierre Quartier, Tianwang Li, Maria T. Gianatasio, Robert P. Hasserjian, Lauren A. Henderson, David B. Sykes, Elizabeth D. Mellins, Scott W. Canna, Julia F. Charles, Peter A. Nigrovic, Pui Y. Lee
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Still’s disease is an inflammatory syndrome linked to the development of further immune dysregulation and hypercytokinaemia termed macrophage activation syndrome. Here the authors implicate the mechanistic target of rapamycin complex 1 in murine mo
Externí odkaz:
https://doaj.org/article/0b6c3e1af33b4a6dbc1260fdb044deab
Autor:
David B. Chou, Brooke A. Furlong, Ryan R. Posey, Christos Kyprianou, Lucy R. O’Sullivan, Rhiannon David, Suzanne J. Randle, Urszula M. Polanska, Jon Travers, Jelena Urosevic, John N. Hutchinson, Jianwei Che, Anna M. Howley, Robert P. Hasserjian, Rachelle Prantil-Baun, Donald E. Ingber
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Patients treated with Aurora kinase inhibitors experience dose-limiting neutropenia while other cytopenias are rare. Here, Chou et al. show that this cell-type specific side effect is partly explained by loss of drug efflux pump expression during neu
Externí odkaz:
https://doaj.org/article/30b138eaa22049aea33459bc0a7f87f2
Autor:
Rami S. Komrokji, Somdeb Ball, Giulia Maggioni, Erica Travaglino, Najla Al Ali, Pierre Fenaux, Uwe Platzbecker, Valeria Santini, María Díez Campelo, Torsten Haferlach, Avani Singh, Akriti Jain, Luis E. Aguirre, Sara Tinsley, Zaker Schwabkey, Onyee Chan, Zhuoer Xie, Andrew Brunner, Andrew Kuykendall, John Bennett, Rena Buckstein, Rafael Bejar, Jan Bewersdorf, Hetty Carraway, Amy Dezern, Elizabeth A. Griffiths, Stephanie Halene, Robert Paul Hasserjian, Sanam Loghavi, Olatoyosi Odenike, Mrinal Patnaik, Gail Roboz, Maximillian Stahl, Mikkael Sekeres, David Steensma, Michael Robert Savona, Justin Taylor, Mina Xu, Kendra Sweet, Jeffrey Lancet, Alan List, Eric Padron, David Sallman, Amer M. Zeidan, Matteo Giovanni Della Porta
Publikováno v:
HemaSphere, Vol 7, p e616260d (2023)
Externí odkaz:
https://doaj.org/article/b4b52b43ce5f470e85edcd6a9e189772
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3322-3332 (2019)
Abstract: Recent work has identified distinct molecular subgroups of acute myeloid leukemia (AML) with implications for disease classification and prognosis. AML with mutated NPM1 (AML-NPM1) represents a distinct entity in the revised 2017 World Heal
Externí odkaz:
https://doaj.org/article/e74c65d6a6be45438968b04788c0d354
Publikováno v:
Seminars in Diagnostic Pathology. 40:152-171
Autor:
Mina L. Xu, Robert P. Hasserjian
Publikováno v:
The Cancer Journal. 29:122-129